The Centers for Medicare & Medicaid Services Oct. 17 issued a reminder that participants in the mandatory should have a representative complete the . The form identifies two individuals to serve as primary contacts for TEAM-related updates and communication with CMS. Hospitals can check the of participants that CMS published in order to verify whether they were selected for the model. 

In addition, CMS reiterated a one-time voluntary opt-in opportunity for hospitals participating in the Bundled Payments for Care Improvement Advanced Model until Dec. 31, 2025 and those participating in the Comprehensive Care for Joint Replacement Model until Dec. 31, 2024. Eligible and interested hospitals must submit a written participation election letter to CMS between Jan. 1-31, 2025. CMS said it would provide details about the form and submission process closer to the date.

Related News Articles

Headline
The AHA June 16 released a report showing hospitals that participated in the 340B Drug Pricing Program are not only subject to disproportionately greater…
Chairperson's File
Public
Advocacy is such an important part of what we do as hospitals and health systems — and what the AHA does on behalf of our field — to help ensure that we get…
Headline
The AHA June 4 filed an amicus brief in the U.S. District Court for the Middle District of Tennessee in defense of the state’s 340B contract pharmacy law…
Headline
A U.S. district court judge for the District of Columbia May 15 ruled the Department of Health and Human Services must preapprove the use of 340B “rebate…
Headline
The AHA May 14 filed an amicus brief in the U.S. District Court for the District of South Dakota in defense of the state’s 340B contract pharmacy law…
Headline
The AHA May 9 urged the Department of Health and Human Services to deny drug companies’ requests to approve their unlawful 340B rebate models. “The 340B…